85   Jansen N.A., Cestèle S., Marco S.S., Schenke M., Stewart K., Patel J., Tolner E.A., Brunklaus A., Mantegazza M. and van den Maagdenberg AMJ.M. (2024). Brainstem depolarization-induced lethal apnea associated with gain-of-function SCN1A(L263V) is prevented by sodium channel blockade. Proc Natl Acad Sci U S A, 121 (14) : e2309000121

84   Smith J., Richerson G., Kouchi H., Duprat F., Mantegazza M., Bezin L. and Rheims S. (2023). Are we there yet ? : A critical evaluation of SUDEP models. Epilepsia, () :

83   Rusina E., Simonti M., Duprat F., Cestèle S. and Mantegazza M. (2023). Voltage-gated sodium channels in genetic epilepsy: up and down of excitability. J Neurochem, () :

82   Lemaire L., Desroches M., Krupa M. and Mantegazza M. (2023). Idealized multiple-timescale model of cortical spreading depolarization initiation and pre-epileptic hyperexcitability caused by Na(V)1.1/SCN1A mutations. J Math Biol, 86 (6) : 92

81   Scalmani P., Paterra R., Mantegazza M., Avoli M. and de Curtis M. (2023). Involvement of GABAergic interneuron subtypes in 4-aminopyridine-induced seizure-like events in mouse entorhinal cortex in vitro. J Neurosci, () :

80   Matricardi S., Cestèle S., Trivisano M., Kassabian B., Leroudier N., Vittorini R., Nosadini M., Cesaroni E., Siliquini S., Marinaccio C., Longaretti F., Podestà B., Operto F.F., Luisi C., Sartori S., Boniver C., Specchio N., Vigevano F., Marini C. and Mantegazza M. (2023). Gain of function SCN1A disease-causing variants: expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication. Epilepsia, () :

79   Mantegazza M. and Cestèle S. (2022). Predictive precision medicine efforts for voltage-gated sodium channel genetic variants. Brain, () :

78   Mantegazza M., Auvin S., Barker-Haliski M., Katsarou A.M., Kubova H., Galanopoulou A.S., Semple B. and Reid C.A. (2022). A companion to the preclinical common data elements for rodent genetic epilepsy models. A Report of the TASK3-WG1B: Pediatric and Genetic models Working Group of the ILAE/AES Joint Translational Task Force. Epilepsia Open, () :

77   Guerrini R., Conti V., Mantegazza M., Balestrini S., Galanopoulou A.S. and Benfenati F. (2022). Developmental and epileptic encephalopathies: from genetic heterogeneity to phenotypic continuum. Physiol Rev, () :

76   Katsarou A.M., Kubova H., Auvin S., Mantegazza M., Barker-Haliski M., Galanopoulou A.S., Reid C.A. and Semple B.D. (2022). A companion to the preclinical common data elements for rodent models of pediatric acquired epilepsy: A report of the TASK3-WG1B, Pediatric and Genetic Models Working Group of the ILAE/AES Joint Translational Task Force. Epilepsia Open, () :

75   Brunklaus A., Brünger T., Feng T., Fons C., Lehikoinen A., Panagiotakaki E., Vintan M.A., Symonds J., Andrew J., Arzimanoglou A., Delima S., Gallois J., Hanrahan D., Lesca G., MacLeod S., Marjanovic D., McTague A., Nuñez-Enamorado N., Perez-Palma E., Scott Perry M., Pysden K., Russ-Hall S.J., Scheffer I.E., Sully K., Syrbe S., Vaher U., Velayutham M., Vogt J., Weiss S., Wirrell E., Zuberi S.M., Lal D., Møller R.S., Mantegazza M. and Cestèle S. (2022). The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications. Brain, () :

74   Beretta S., Gritti L., Ponzoni L., Scalmani P., Mantegazza M., Sala M., Verpelli C. and Sala C. (2022). Rescuing epileptic and behavioral alterations in a Dravet syndrome mouse model by inhibiting eukaryotic elongation factor 2 kinase (eEF2K). Mol Autism, 13 (1) : 1

73   Chever O., Zerimech S., Scalmani P., Lemaire L., Pizzamiglio L., Loucif A., Ayrault M., Krupa M., Desroches M., Duprat F., Léna I., Cestèle S. and Mantegazza M. (2021). Initiation of migraine-related cortical spreading depolarization by hyperactivity of GABAergic neurons and NaV1.1 channels. J Clin Invest, () :

72   Lemaire L., Desroches M., Krupa M., Pizzamiglio L., Scalmani P. and Mantegazza M. (2021). Modeling NaV1.1/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine. PLoS Comput Biol, 17 (7) : e1009239

71   Alari V., Scalmani P., Ajmone P.F., Perego S., Avignone S., Catusi I., Lonati P.A., Borghi M.O., Finelli P., Terragni B., Mantegazza M., Russo S. and Larizza L. (2021). Histone Deacetylase Inhibitors Ameliorate Morphological Defects and Hypoexcitability of iPSC-Neurons from Rubinstein-Taybi Patients. Int J Mol Sci, 22 (11) :

70   Mantegazza M., Cestèle S. and Catterall W. (2021). Sodium Channelopathies of Skeletal Muscle and Brain. Physiol Rev, () :

69   Montnach J., De Waard S., Nicolas S., Burel S., Osorio N., Zoukimian C., Mantegazza M., Boukaiba R., Béroud R., Partiseti M., Delmas P., Marionneau C. and De Waard M. (2021). Fluorescent- and tagged-protoxin II peptides: potent markers of the Na(v) 1.7 channel pain target. Br J Pharmacol, () :

68   Culotta L., Scalmani P., Vinci E., Terragni B., Sessa A., Broccoli V., Mantegazza M. and Verpelli C. (2020). SULT4A1 modulates synaptic development and function by promoting the formation of PSD-95/NMDAR complex. J Neurosci, () :

67   Zerimech S., Chever O., Scalmani P., Pizzamiglio L., Duprat F. and Mantegazza M. (2020). Cholinergic modulation inhibits cortical spreading depression in mouse neocortex through activation of muscarinic receptors and decreased excitatory/inhibitory drive. Neuropharmacology, () : 107951

66   Mantegazza M. and Broccoli V. (2019). SCN1A/NaV 1.1 channelopathies: Mechanisms in expression systems, animal models, and human iPSC models. Epilepsia, 60 Suppl 3 () : S25-S38

65   Desroches M., Faugeras O., Krupa M. and Mantegazza M. (2019). Modeling cortical spreading depression induced by the hyperactivity of interneurons. J Comput Neurosci, () :

64   Lena I. and Mantegazza M. (2019). NaV1.2 haploinsufficiency in Scn2a knock-out mice causes an autistic-like phenotype attenuated with age. Sci Rep, 9 (1) : 12886

63   Marcuzzo S., Terragni B., Bonanno S., Isaia D., Cavalcante P., Cappelletti C., Ciusani E., Rizzo A., Regalia G., Yoshimura N., Ugolini G.S., Rasponi M., Bechi G., Mantegazza M., Mantegazza R., Bernasconi P. and Minati L. (2019). Hyperexcitability in Cultured Cortical Neuron Networks from the G93A-SOD1 Amyotrophic Lateral Sclerosis Model Mouse and its Molecular Correlates. Neuroscience, () :

62   Corti A., Sota R., Dugo M., Calogero R.A., Terragni B., Mantegazza M., Franceschetti S., Restelli M., Gasparini P., Lecis D., Chrzanowska K.H. and Delia D. (2019). DNA damage and transcriptional regulation in iPSC-derived neurons from Ataxia Telangiectasia patients. Sci Rep, 9 (1) : 651

61   Salgueiro-Pereira A.R., Duprat F., Pousinha P., Loucif A., Douchamps V., Regondi C., Ayrault M., Eugie M., Stunault M.I., Escayg A., Goutagny R., Gnatkovsky V., Frassoni C., Marie H., Bethus I. and Mantegazza M. (2019). A two-hit story: Seizures and genetic mutation interaction sets phenotype severity in SCN1A epilepsies. Neurobiol Dis, () :

60   Contesse T., Ayrault M., Mantegazza M., Studer M. and Deschaux O. (2019). Hyperactive and anxiolytic-like behaviors result from loss of COUP-TFI/Nr2f1 in the mouse cortex. Genes Brain Behav, () : e12556

59   Castagnola S., Delhaye S., Folci A., Paquet A., Brau F., Duprat F., Jarjat M., Grossi M., Beal M., Martin S., Mantegazza M., Bardoni B. and Maurin T. (2018). New Insights Into the Role of Cav2 Protein Family in Calcium Flux Deregulation in Fmr1-KO Neurons. Front Mol Neurosci, 11 () : 342

58   Dhifallah S., Lancaster E., Merrill S., Leroudier N., Mantegazza M. and Cestele S. (2018). Gain of Function for the SCN1A/hNav1.1-L1670W Mutation Responsible for Familial Hemiplegic Migraine. Front Mol Neurosci, 11 () : 232

57   May P., Girard S., Harrer M., Bobbili D.R., Schubert J., Wolking S., Becker F., Lachance-Touchette P., Meloche C., Gravel M., Niturad C.E., Knaus J., De Kovel C., Toliat M., Polvi A., Iacomino M., Guerrero-Lopez R., Baulac S., Marini C., Thiele H., Altmuller J., Jabbari K., Ruppert A.K., Jurkowski W., Lal D., Rusconi R., Cestele S., Terragni B., Coombs I.D., Reid C.A., Striano P., Caglayan H., Siren A., Everett K., Moller R.S., Hjalgrim H., Muhle H., Helbig I., Kunz W.S., Weber Y.G., Weckhuysen S., Jonghe P., Sisodiya S.M., Nabbout R., Franceschetti S., Coppola A., Vari M.S., Kasteleijn-Nolst Trenite D., Baykan B., Ozbek U., Bebek N., Klein K.M., Rosenow F., Nguyen D.K., Dubeau F., Carmant L., Lortie A., Desbiens R., Clement J.F., Cieuta-Walti C., Sills G.J., Auce P., Francis B., Johnson M.R., Marson A.G., Berghuis B., Sander J.W., Avbersek A., McCormack M., Cavalleri G.L., Delanty N., Depondt C., Krenn M. and Zim (2018). Rare coding variants in genes encoding GABAA receptors in genetic generalised epilepsies: an exome-based case-control study. Lancet Neurol, 17 (8) : 699-708

56   Alari V., Russo S., Terragni B., Ajmone P.F., Sironi A., Catusi I., Calzari L., Concolino D., Marotta R., Milani D., Giardino D., Mantegazza M., Gervasini C., Finelli P. and Larizza L. (2018). iPSC-derived neurons of CREBBP- and EP300-mutated Rubinstein-Taybi syndrome patients show morphological alterations and hypoexcitability. Stem Cell Res, 30 () : 130-140

55   Mantegazza M. and Cestele S. (2017). Pathophysiological mechanisms of migraine and epilepsy: similarities and differences. Neurosci Lett, () :

54   Mantegazza M. (2017). Epilepsy: Advances in Genetics and Pathophysiology. Neurosci Lett, () :

53   Binini N., Sancini G., Villa C., Magro R.D., Sansoni V., Rusconi R., Mantegazza M., Grioni D., Talpo F., Toselli M. and Combi R. (2017). Identification of two mutations in cis in the SCN1A gene in a family showing genetic epilepsy with febrile seizures plus (GEFS+) and idiopathic generalized epilepsy (IGE). Brain Res, () :

52   Montani C., Ramos-Brossier M., Ponzoni L., Gritti L., Cwetsch A.W., Braida D., Saillour Y., Terragni B., Mantegazza M., Sala M., Verpelli C., Billuart P. and Sala C. (2017). The X-linked intellectual disability protein IL1RAPL1 regulates dendrite complexity. J Neurosci, () :

51   Terragni B., Scalmani P., Franceschetti S., Cestele S. and Mantegazza M. (2017). Post-translational dysfunctions in channelopathies of the nervous system. Neuropharmacology, () :

50   Avanzini G., Mantegazza M., Terragni B., Canafoglia L., Scalmani P. and Franceschetti S. (2017). The impact of genetic and experimental studies on classification and therapy of the epilepsies. Neurosci Lett, () :

49   Kapetis D., Sassone J., Yang Y., Galbardi B., Xenakis M.N., Westra R.L., Szklarczyk R., Lindsey P., Faber C.G., Gerrits M., Merkies I.S., Dib-Hajj S.D., Mantegazza M., Waxman S.G. and Lauria G. (2017). Network topology of NaV1.7 mutations in sodium channel-related painful disorders. BMC Syst Biol, 11 (1) : 28

48   Khalfallah O., Jarjat M., Davidovic L., Nottet N., Cestele S., Mantegazza M. and Bardoni B. (2016). Depletion of the Fragile X Mental Retardation Protein in Embryonic Stem Cells Alters the Kinetics of Neurogenesis. Stem Cells, () :

47   Terragni B., Scalmani P., Colombo E., Franceschetti S. and Mantegazza M. (2016). Ranolazine vs phenytoin: greater effect of ranolazine on the transient Na+ current than on the persistent Na+ current in central neurons. Neuropharmacology, 110 (Pt A) : 223-236

46   Vicidomini C., Ponzoni L., Lim D., Schmeisser M.J., Reim D., Morello N., Orellana D., Tozzi A., Durante V., Scalmani P., Mantegazza M., Genazzani A.A., Giustetto M., Sala M., Calabresi P., Boeckers T.M., Sala C. and Verpelli C. (2016). Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice. Mol Psychiatry, () :

45   De Stasi A.M., Farisello P., Marcon I., Cavallari S., Forli A., Vecchia D., Losi G., Mantegazza M., Panzeri S., Carmignoto G., Bacci A. and Fellin T. (2016). Unaltered Network Activity and Interneuronal Firing During Spontaneous Cortical Dynamics In Vivo in a Mouse Model of Severe Myoclonic Epilepsy of Infancy. Cereb Cortex, () :

44   Bechi G., Rusconi R., Cestele S., Striano P., Franceschetti S. and Mantegazza M. (2015). Rescuable folding defective Na1.1 (SCN1A) mutants in epilepsy: Properties, occurrence, and novel rescuing strategy with peptides targeted to the endoplasmic reticulum. Neurobiol Dis, () :

43   Hedrich U.B., Liautard C., Kirschenbaum D., Pofahl M., Lavigne J., Liu Y., Theiss S., Slotta J., Escayg A., Dihne M., Beck H., Mantegazza M. and Lerche H. (2014). Impaired Action Potential Initiation in GABAergic Interneurons Causes Hyperexcitable Networks in an Epileptic Mouse Model Carrying a Human NaV1.1 Mutation. J Neurosci, 34 (45) : 14874-89

42   Li T., Tian C., Scalmani P., Frassoni C., Mantegazza M., Wang Y., Yang M., Wu S. and Shu Y. (2014). Action Potential Initiation in Neocortical Inhibitory Interneurons. PLoS Biol, 12 (9) : e1001944

41   Carlessi L., Poli E.F., Bechi G., Mantegazza M., Pascucci B., Narciso L., Dogliotti E., Sala C., Verpelli C., Lecis D. and Delia D. (2014). Functional and molecular defects of hiPSC-derived neurons from patients with ATM deficiency. Cell Death Dis, 5 () : e1342

40   Guerrini R., Marini C. and Mantegazza M. (2014). Genetic Epilepsy Syndromes Without Structural Brain Abnormalities: Clinical Features and Experimental Models. Neurotherapeutics, () :

39   Verpelli C., Carlessi L., Bechi G., Poli E.F., Orellana D., Heise C., Franceschetti S., Mantegazza R., Mantegazza M., Delia D. and Sala C. (2013). Comparative neuronal differentiation of self-renewing neural progenitor cell lines obtained from human induced pluripotent stem cells. Front Cell Neurosci, 7 () : 175

38   Cestele S., Schiavon E., Rusconi R., Franceschetti S. and Mantegazza M. (2013). Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects. Proc Natl Acad Sci U S A, () :

37   Partemi S., Cestele S., Pezzella M., Campuzano O., Paravidino R., Pascali V.L., Zara F., Tassinari C.A., Striano S., Oliva A., Brugada R., Mantegazza M. and Striano P. (2013). Loss-of-function KCNH2 mutation in a family with long QT syndrome, epilepsy, and sudden death. Epilepsia, 54 (8) : e112-6

36   Liautard C., Scalmani P., Carriero G., de Curtis M., Franceschetti S. and Mantegazza M. (2013). Hippocampal hyperexcitability and specific epileptiform activity in a mouse model of Dravet syndrome. Epilepsia, () :

35   Cestele S., Labate A., Rusconi R., Tarantino P., Mumoli L., Franceschetti S., Annesi G., Mantegazza M. and Gambardella A. (2013). Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine. Epilepsia, () :

34   Colombo E., Franceschetti S., Avanzini G. and Mantegazza M. (2013). Phenytoin inhibits the persistent sodium current in neocortical neurons by modifying its inactivation properties. PLoS One, 8 (1) : e55329

33   Mantegazza M. and Catterall W.A. (2012). Voltage-Gated Na+ Channels: Structure, Function, and Pathophysiology , () :

32   Bechi G., Scalmani P., Schiavon E., Rusconi R., Franceschetti S. and Mantegazza M. (2012). Pure haploinsufficiency for Dravet syndrome Na(V)1.1 (SCN1A) sodium channel truncating mutations. Epilepsia, 53 (1) : 87-100

31   Marini C. and Mantegazza M. (2010). Na(+) channelopathies and epilepsy: recent advances and new perspectives. Expert Rev Clin Pharmacol, 3 (3) : 371-84

30   Mantegazza M. (2011). Dravet syndrome: insights from in vitro experimental models. Epilepsia, 52 Suppl 2 () : 62-9

29   Espino-Solis G.P., Estrada G., Olamendi-Portugal T., Villegas E., Zamudio F., Cestele S., Possani L.D. and Corzo G. (2011). Isolation and molecular cloning of beta-neurotoxins from the venom of the scorpion Centruroides suffusus suffusus. Toxicon, 57 (5) : 739-46

28   Mantegazza M., Rusconi R., Scalmani P., Avanzini G. and Franceschetti S. (2010). Epileptogenic ion channel mutations: from bedside to bench and, hopefully, back again. Epilepsy Res, 92 (1) : 1-29

27   Mantegazza M., Curia G., Biagini G., Ragsdale D.S. and Avoli M. (2010). Voltage-gated sodium channels as therapeutic targets in epilepsy and other Lancet Neurol, 9 (4) : 413-24

26   Riva D., Vago C., Pantaleoni C., Bulgheroni S., Mantegazza M. and Franceschetti S. (2009). Progressive neurocognitive decline in two children with Dravet syndrome, de novo Am J Med Genet A, 149A (10) : 2339-45

25   Tang B., Dutt K., Papale L., Rusconi R., Shankar A., Hunter J., Tufik S., Yu F.H., Catterall W.A., Mantegazza M., Goldin A.L. and Escayg A. (2009). A BAC transgenic mouse model reveals neuron subtype-specific effects of a Neurobiol Dis, 35 (1) : 91-102

24   Rusconi R., Combi R., Cestele S., Grioni D., Franceschetti S., Dalpra L. and Mantegazza M. (2009). A rescuable folding defective Nav1.1 (SCN1A) sodium channel mutant causes GEFS+: Hum Mutat, 30 (7) : E747-60

23   Cestele S., Scalmani P., Rusconi R., Terragni B., Franceschetti S. and Mantegazza M. (2008). Self-limited hyperexcitability: functional effect of a familial hemiplegic J Neurosci, 28 (29) : 7273-83

22   Rusconi R., Scalmani P., Cassulini R.R., Giunti G., Gambardella A., Franceschetti S., Annesi G., Wanke E. and Mantegazza M. (2007). Modulatory proteins can rescue a trafficking defective epileptogenic Nav1.1 Na+ J Neurosci, 27 (41) : 11037-46

21   Avanzini G., Franceschetti S. and Mantegazza M. (2007). Epileptogenic channelopathies: experimental models of human pathologies. Epilepsia, 48 Suppl 2 () : 51-64

20   Colosimo E., Gambardella A., Mantegazza M., Labate A., Rusconi R., Schiavon E., Annesi F., Cassulini R.R., Carrideo S., Chifari R., Canevini M.P., Canger R., Franceschetti S., Annesi G., Wanke E. and Quattrone A. (2007). Electroclinical features of a family with simple febrile seizures and temporal Epilepsia, 48 (9) : 1691-6

19   Curia G., Aracri P., Colombo E., Scalmani P., Mantegazza M., Avanzini G. and Franceschetti S. (2007). Phosphorylation of sodium channels mediated by protein kinase-C modulates Br J Pharmacol, 150 (6) : 792-7

18   Scalmani P., Rusconi R., Armatura E., Zara F., Avanzini G., Franceschetti S. and Mantegazza M. (2006). Effects in neocortical neurons of mutations of the Na(v)1.2 Na+ channel causing J Neurosci, 26 (40) : 10100-9

17   Yu F.H., Mantegazza M., Westenbroek R.E., Robbins C.A., Kalume F., Burton K.A., Spain W.J., McKnight G.S., Scheuer T. and Catterall W.A. (2006). Reduced sodium current in GABAergic interneurons in a mouse model of severe Nat Neurosci, 9 (9) : 1142-9

16   Aracri P., Colombo E., Mantegazza M., Scalmani P., Curia G., Avanzini G. and Franceschetti S. (2006). Layer-specific properties of the persistent sodium current in sensorimotor J Neurophysiol, 95 (6) : 3460-8

15   Mantegazza M., Gambardella A., Rusconi R., Schiavon E., Annesi F., Cassulini R.R., Labate A., Carrideo S., Chifari R., Canevini M.P., Canger R., Franceschetti S., Annesi G., Wanke E. and Quattrone A. (2005). Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation Proc Natl Acad Sci U S A, 102 (50) : 18177-82

14   Mantegazza M. and Cestele S. (2005). Beta-scorpion toxin effects suggest electrostatic interactions in domain II of J Physiol, 568 (Pt 1) : 13-30

13   Mantegazza M., Yu F.H., Powell A.J., Clare J.J., Catterall W.A. and Scheuer T. (2005). Molecular determinants for modulation of persistent sodium current by G-protein J Neurosci, 25 (13) : 3341-9

12   Srairi-Abid N., Guijarro J.I., Benkhalifa R., Mantegazza M., Cheikh A., Ben Aissa M., Haumont P.Y., Delepierre M. and El Ayeb M. (2005). A new type of scorpion Na+-channel-toxin-like polypeptide active on K+ channels. Biochem J, 388 (Pt 2) : 455-64

11   M'Barek S., Fajloun Z., Cestele S., Devaux C., Mansuelle P., Mosbah A., Jouirou B., Mantegazza M., Van Rietschoten J., El Ayeb M., Rochat H., Sabatier J.M. and Sampieri F. (2004). First chemical synthesis of a scorpion alpha-toxin affecting sodium channels: the J Pept Sci, 10 (11) : 666-77

10   Curia G., Aracri P., Sancini G., Mantegazza M., Avanzini G. and Franceschetti S. (2004). Protein-kinase C-dependent phosphorylation inhibits the effect of the Neuroscience, 127 (1) : 63-8

9   Mantegazza M., Yu F.H., Catterall W.A. and Scheuer T. (2001). Role of the C-terminal domain in inactivation of brain and cardiac sodium Proc Natl Acad Sci U S A, 98 (26) : 15348-53

8   Cestele S., Scheuer T., Mantegazza M., Rochat H. and Catterall W.A. (2001). Neutralization of gating charges in domain II of the sodium channel alpha subunit J Gen Physiol, 118 (3) : 291-302

7   Taverna S., Sancini G., Mantegazza M., Franceschetti S. and Avanzini G. (1999). Inhibition of transient and persistent Na+ current fractions by the new J Pharmacol Exp Ther, 288 (3) : 960-8

6   Taverna S., Mantegazza M., Franceschetti S. and Avanzini G. (1998). Valproate selectively reduces the persistent fraction of Na+ current in Epilepsy Res, 32 (1-2) : 304-8

5   Magistretti J., Mantegazza M., de Curtis M. and Wanke E. (1998). Modalities of distortion of physiological voltage signals by patch-clamp Biophys J, 74 (2 Pt 1) : 831-42

4   Mantegazza M., Franceschetti S. and Avanzini G. (1998). Anemone toxin (ATX II)-induced increase in persistent sodium current: effects on J Physiol, 507 ( Pt 1) () : 105-16

3   Magistretti J., Mantegazza M., Guatteo E. and Wanke E. (1996). Action potentials recorded with patch-clamp amplifiers: are they genuine? Trends Neurosci, 19 (12) : 530-4

2   Wanke E., Bianchi L., Mantegazza M., Guatteo E., Mancinelli E. and Ferroni A. (1994). Muscarinic regulation of Ca2+ currents in rat sensory neurons: channel and Eur J Neurosci, 6 (3) : 381-91

1   Mantegazza M., Fasolato C., Hescheler J. and Pietrobon D. (1995). Stimulation of single L-type calcium channels in rat pituitary GH3 cells by EMBO J, 14 (6) : 1075-83